Utilizing its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine capabilities, Roche Innovation Center Copenhagen aims to deliver effective and well tolerated RNA-targeted therapies that have the ability to inhibit and cure diseases and to improve the quality of life of patients with critical diseases where options are inadequate or do not exist.
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.
Community Guidelines: bit.ly/2MgAcio
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com.
Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/
Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/